Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Diabetes

Journal Scan / Research · February 15, 2023

Safety and Efficacy of Once-Weekly Basal Insulin Fc in People With Type 2 Diabetes Previously Treated With Basal Insulin

The Lancet Diabetes & Endocrinology


Additional Info

Disclosure statements are available on the authors' profiles:

The Lancet Diabetes & Endocrinology
Safety and efficacy of once-weekly basal insulin Fc in people with type 2 diabetes previously treated with basal insulin: a multicentre, open-label, randomised, phase 2 study
Lancet Diabetes Endocrinol 2023 Feb 06;[EPub Ahead of Print], J Frias, J Chien, Q Zhang, E Chigutsa, W Landschulz, K Syring, P Wullenweber, A Haupt, C Kazda

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading